BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 28 filers reported holding BIOLINERX LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,000 | -10.0% | 24,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $10,000 | -9.1% | 24,000 | 0.0% | 0.01% | -25.0% |
| Q4 2018 | $11,000 | -80.0% | 24,000 | -51.0% | 0.01% | -73.3% |
| Q3 2018 | $55,000 | +25.0% | 49,000 | 0.0% | 0.03% | +36.4% |
| Q2 2018 | $44,000 | +2.3% | 49,000 | 0.0% | 0.02% | -4.3% |
| Q1 2018 | $43,000 | -15.7% | 49,000 | +11.4% | 0.02% | -20.7% |
| Q3 2017 | $51,000 | +466.7% | 44,000 | +300.0% | 0.03% | +480.0% |
| Q2 2017 | $9,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,501,000 | $2,432,000 | 0.47% |
| Senvest Management, LLC | 2,278,995 | $3,692,000 | 0.26% |
| Opaleye Management Inc. | 250,000 | $405,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 928,758 | $1,505,000 | 0.05% |
| Benchmark Capital Advisors | 40,000 | $65,000 | 0.04% |
| Orbimed Advisors | 1,135,000 | $1,839,000 | 0.02% |
| NEXT Financial Group, Inc | 28,500 | $46,000 | 0.02% |
| Cutter & CO Brokerage, Inc. | 10,000 | $16,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 110 | $0 | 0.00% |
| Renaissance Technologies | 26,878 | $44,000 | 0.00% |